By Art Gross – On May 11, 2023, the PHE declaration expired. With this, the relaxed regulations and waivers put in place during the pandemic expired, and providers need to return to full compliance with HIPAA regulations. Be sure your policies and procedures for safeguarding PHI are up to date.
Read More
By Devin Partida – The COVID-19 public health and national emergency declarations will end on May 11, 2023. This marks the official end of the health emergency that began in January 2020. While this is good news, it also means some things are going to change regarding vaccine and testing availability.
By Devin Partida – Most people who get sick with the COVID-19 virus get better after a week or two. However, more severe cases require hospitalization and linger for much longer. Others notice their symptoms go away for a while and reappear after one or more months.
The AMA announced an editorial update to Current Procedural Terminology (CPT)®, the nation’s leading medical terminology code set for describing health care procedures and services, that includes eight new codes for the bivalent COVID-19 vaccine booster doses from Moderna and Pfizer-BioNTech.
By Matt Fisher – How many people remember how healthcare fully operated prior to the onset of the COVID-19 driven pandemic? The question is only somewhat facetious as the delivery of care and running of organizations along with so many other components of the healthcare industry have changed to a large degree.
The health IT industry is driven by growing demand for improved patient safety and patient care as well as increase in government initiatives to promote and adopt health IT. It is estimated to reach $149,178 million by 2025. Here is product news that is making these number real.
The pharmaceutical market plays a key role in how people get medications and what people pay for medication. At the intersection of healthcare, pharma, and technology, here are current news and announcements.
The American Medical Association announced an editorial update to the Current Procedural Terminology code set that includes a new vaccine administration code for a third dose of the pediatric COVID-19 vaccine developed by Pfizer.
By Jeff Shuren MD JD & William Maisel MD MPH – Since the onset of the COVID-19 pandemic, staff at the FDA’s Center for Devices and Radiological Health have worked tirelessly to manage unprecedented workload demands to help increase access to high quality, critical products that are essential to our nation’s pandemic response.